J30.1 J30.2 J30.3 J30.4 J45.0 J45.8
Conditions
Interventions
Group 1: allergic rhinitis and no AIT
(one-time patient survey and routine data analysis)
Group 2: allergic rhinitis and AIT (see arm 1)
Group 3: allergic asthma and no AIT (see arm 1)
Group 4: allerg
Sponsors
Lehrstuhl für Medizinmanagement, Universität Duisburg-Essen
Eligibility
Sex/Gender
All
Age
5 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria for insurred with allergic rhinitis: in the index period (01.07.2017-30.06.2018) at least 5 years old, at least one secure outpatient diagnosis (J30.1; J30.2; J30.3 or J30.4) in at least one quarter, insured by the DAK Gesundheit in the index period and the previous four years. Inclusion criteria for insured with allergic asthma: in the index period (01.07.2017-30.06.2018), at least 5 years old, at least secure outpatient diagnosis in at least two quarter or an inpatient diagnosis in at least one quarter, at least one of the below listed drugs prescribed, insurred by the DAK Gesundheit in the index period and the previous four years. ATC-Code asthma medication: R03AA, R03AC, R03AK, R03BA, R03BB, R03BC, R03CB, R03CC, R03DA, R03DC, R03DH, R03DX
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| by questionnaire and routine data: existing of a deficent care situation regarding AIT | — |
Secondary
| Measure | Time frame |
|---|---|
| by questionnaire and routine data: patient characteristics which correlates with a deficient care situation regarding AIT; health related quality of life; cost of illness | — |
Countries
Germany
Contacts
Public ContactFrederik Valbert
Lehrstuhl für Medizinmanagement, Universität Duisburg-Essen
Outcome results
None listed